Foxa2tm1(cre)Heli/Foxa2tm1(cre)Heli
B6.129S2-Foxa2tm1(cre)Heli
|
normal
mortality/aging |
J:142568
|
Foxa2tm1(cre/ERT2)Hssk/Foxa2tm1(cre/ERT2)Hssk
involves: C57BL/6J * C57BL/6NCrlj * CBA/JNCrlj * ICR
|
no abnormal phenotype detected |
J:194054
|
Foxa2tm1.1Khk/Foxa2+
involves: 129P2/OlaHsd * C57BL/6 * CD-1
|
abnormal respiratory mucosa goblet cell morphology |
J:284174
|
increased susceptibility to injury |
J:284174
|
respiratory system inflammation |
J:284174
|
Foxa2tm1.1Stf/Foxa2tm1.1Stf
B6.129-Foxa2tm1.1Stf
|
hyperactivity |
J:155391
|
increased carbon dioxide production |
J:155391
|
increased fluid intake |
J:155391
|
increased food intake |
J:155391
|
increased oxygen consumption |
J:155391
|
Foxa2tm1.1Stf/Foxa2tm1.1Stf Tg(Nes-cre)1Kln/0
B6.Cg-Foxa2tm1.1Stf Tg(Nes-cre)1Kln
|
decreased circulating free fatty acids level |
J:155391
|
decreased circulating glucose level |
J:155391
|
decreased circulating insulin level |
J:155391
|
decreased total body fat amount |
J:155391
|
hyperactivity |
J:155391
|
improved glucose tolerance |
J:155391
|
increased basal metabolism |
J:155391
|
increased carbon dioxide production |
J:155391
|
increased fluid intake |
J:155391
|
increased food intake |
J:155391
|
increased insulin sensitivity |
J:155391
|
increased lean body mass |
J:155391
|
increased oxygen consumption |
J:155391
|
Foxa2tm1Dnl/Foxa2+
involves: 129P2/OlaHsd * C57BL/6J
|
abnormal gait |
J:19896
|
abnormal glucose homeostasis |
J:95662
|
abnormal metabolism |
J:95662
|
absent estrous cycle |
J:19896
|
absent estrus |
J:19896
|
impaired righting response |
J:19896
|
increased circulating free fatty acids level |
J:95662
|
increased circulating triglyceride level |
J:95662
|
increased liver triglyceride level |
J:95662
|
increased miscarriage rate |
J:19896
|
malocclusion |
J:19896
|
neonatal lethality, incomplete penetrance |
J:19896
|
reduced female fertility |
J:19896
|
Foxa2tm1Dnl/Foxa2tm1Dnl
involves: 129P2/OlaHsd * C57BL/6J
|
abnormal cell death |
J:19896
|
abnormal chordamesoderm morphology |
J:19896
|
abnormal embryonic tissue morphology |
J:19896
|
abnormal endoderm development |
J:19896
|
abnormal eye development |
J:19896
|
abnormal nervous system development |
J:19896
|
abnormal neural tube morphology |
J:19896
|
abnormal neuron differentiation |
J:19896
|
abnormal paraxial mesoderm morphology |
J:19896
|
abnormal somite development |
J:19896
|
absent floor plate |
J:19896
|
absent notochord |
J:19896
|
absent primitive node |
J:19896
|
decreased embryo size |
J:19896
|
embryonic lethality during organogenesis, complete penetrance |
J:19896
|
Foxa2tm1Jrt/Foxa2+
involves: 129S1/Sv * 129X1/SvJ
|
circling |
J:19895
|
decreased body size |
J:19895
|
hunched posture |
J:19895
|
long incisors |
J:19895
|
malocclusion |
J:19895
|
postnatal lethality |
J:19895
|
premature death |
J:19895
|
Foxa2tm1Jrt/Foxa2+
involves: 129S1/Sv * 129X1/SvJ * C57BL/6
|
circling |
J:19895
|
decreased body size |
J:19895
|
hunched posture |
J:19895
|
long incisors |
J:19895
|
malocclusion |
J:19895
|
postnatal lethality |
J:19895
|
premature death |
J:19895
|
Foxa2tm1Jrt/Foxa2+
involves: 129S1/Sv * 129X1/SvJ * CD-1
|
circling |
J:19895
|
decreased body size |
J:19895
|
hunched posture |
J:19895
|
long incisors |
J:19895
|
malocclusion |
J:19895
|
postnatal lethality |
J:19895
|
premature death |
J:19895
|
Foxa2tm1Jrt/Foxa2tm1Jrt
involves: 129S1/Sv * 129X1/SvJ
|
abnormal primitive streak elongation |
J:74124
|
abnormal primitive streak formation |
J:74124
|
abnormal rostral-caudal axis patterning |
J:74124
|
absent primitive node |
J:74124
|
Foxa2tm1Jrt/Foxa2tm1Jrt
involves: 129S1/Sv * 129X1/SvJ * C57BL/6
|
absent mesoderm |
J:50810
|
increased embryonic tissue cell apoptosis |
J:50810
|
Foxa2tm1Jrt/Foxa2tm1Jrt
involves: 129S1/Sv * 129X1/SvJ * CD-1
|
abnormal developmental patterning |
J:19895
|
abnormal embryonic tissue morphology |
J:19895
|
abnormal foregut morphology |
J:19895
|
abnormal neural tube morphology |
J:19895
|
abnormal primitive endoderm morphology |
J:19895
|
abnormal primitive streak formation |
J:19895
|
abnormal rostral-caudal axis patterning |
J:19895
|
abnormal somite shape |
J:19895
|
absent floor plate |
J:19895
|
absent mesoderm |
J:50810
|
absent notochord |
J:19895
|
absent primitive node |
J:19895
|
decreased somite size |
J:19895
|
embryonic lethality during organogenesis, complete penetrance |
J:19895
|
embryonic-extraembryonic boundary constriction |
J:19895
|
fused somites |
J:19895
|
increased embryonic tissue cell apoptosis |
J:50810
|
kinked neural tube |
J:19895
|
rostral body truncation |
J:19895
|
Foxa2tm1Jrt/Foxa2tm1Khk Tg(Nes-cre)1Wme/0
involves: 129P2/OlaHsd * C57BL/6 * CBA
|
abnormal forebrain morphology |
J:75055
|
abnormal mesendoderm development |
J:75055
|
embryonic lethality during organogenesis, complete penetrance |
J:75055
|
Foxa2tm1Khk/Foxa2tm1Khk
involves: 129P2/OlaHsd * C57BL/6 * CD-1 * DBA
|
abnormal insulin secretion |
J:70409
|
abnormal pancreatic beta cell morphology |
J:70409
|
decreased circulating glucagon level |
J:70409
|
disorganized pancreatic islets |
J:70409
|
hypoglycemia |
J:70409
|
increased circulating insulin level |
J:70409
|
increased glycogen level |
J:70409
|
postnatal growth retardation |
J:70409
|
postnatal lethality, complete penetrance |
J:70409
|
seizures |
J:70409
|
Foxa2tm1Khk/Foxa2tm1Khk
involves: 129P2/OlaHsd * CD-1
|
no abnormal phenotype detected |
J:63039
|
Foxa2tm1Khk/Foxa2tm1Khk Pgrtm2(cre)Lyd/Pgr+
involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6
|
abnormal decidualization |
J:165229
|
abnormal embryo invasion |
J:165229
|
abnormal endometrial gland development |
J:165229
|
abnormal uterus physiology |
J:165229
|
decreased endometrial gland number |
J:165229
|
decreased litter size |
J:165229
|
impaired embryo implantation |
J:165229
|
reduced female fertility |
J:165229
|
Foxa2tm1Khk/Foxa2tm1Khk Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
involves: 129P2/OlaHsd * C57BL/6 * CD-1 * DBA
|
no abnormal phenotype detected |
J:63039
|
Foxa2tm1Khk/Foxa2tm1Khk Tg(Foxa3-cre)1Khk/0
involves: 129P2/OlaHsd * C57BL/6 * CD-1 * DBA
|
decreased body size |
J:96332
|
decreased circulating glucagon level |
J:96332
|
decreased pancreatic alpha cell number |
J:96332
|
decreased skin turgor |
J:96332
|
disorganized pancreatic islets |
J:96332
|
hypoglycemia |
J:96332
|
postnatal lethality, complete penetrance |
J:96332
|
Foxa2tm1Khk/Foxa2tm1Khk Tg(Scgb1a1-rtTA)1Jaw/0 Tg(tetO-cre)1Jaw/0
Not Specified
|
abnormal respiratory mechanics |
J:88601
|
decreased lung compliance |
J:88601
|
normal
immune system phenotype |
J:88601
|
increased airway resistance |
J:88601
|
increased respiratory mucosa goblet cell number |
J:88601
|
Foxa2tm1Khk/Foxa2tm1Khk Tg(SFTPC-rtTA)5Jaw/0 Tg(tetO-cre)1Jaw/0
involves: 129 * 129P2/OlaHsd * C57BL/6
|
abnormal lung saccule morphology |
J:93473
|
abnormal pulmonary alveolus epithelial cell morphology |
J:93473
|
abnormal pulmonary alveolus wall morphology |
J:93473
|
abnormal surfactant composition |
J:93473
|
abnormal surfactant secretion |
J:93473
|
abnormal type II pneumocyte morphology |
J:93473
|
absent alveolar lamellar bodies |
J:93473
|
absent type I pneumocytes |
J:93473
|
atelectasis |
J:93473
|
cyanosis |
J:93473
|
decreased surfactant secretion |
J:93473
|
dilated respiratory conducting tube |
J:88601
|
impaired lung alveolus development |
J:88601,
J:93473
|
increased macrophage cell number |
J:88601
|
increased neutrophil cell number |
J:88601
|
increased respiratory mucosa goblet cell number |
J:88601
|
neonatal lethality, incomplete penetrance |
J:93473
|
postnatal lethality, incomplete penetrance |
J:88601,
J:93473
|
pulmonary hyaline membrane formation |
J:93473
|
pulmonary vascular congestion |
J:93473
|
pup cannibalization |
J:93473
|
respiratory distress |
J:93473
|
Foxa2tm2(cre/Esr1*)Moon/Foxa2tm2(cre/Esr1*)Moon
Not Specified
|
abnormal craniofacial development |
J:130990
|
delayed heart development |
J:130990
|
embryonic lethality, complete penetrance |
J:130990
|
Foxa2tm2.1Heli/Foxa2tm2.1Heli
involves: 129S6/SvEvTac * C57BL/6 * CD-1 * SJL
|
no abnormal phenotype detected |
J:204475
|